Website Search
In a previous post we noted the increasing importance of biologics as therapeutic agents, with 37% of the drugs approved by the FDA in 2017 being biologic entities. A recent article in Chemical & ...
We address these challenges using OmicsOffice®, an extension to TIBCO Spotfire® focused on genomics data analysis. OmicsOffice makes it easy to analyze and integrate microarray, PCR, RNA-Seq and Chip-Seq data to identify significant targets that were validated across many platforms and technologies.
Your login attempt was not successful. Please try again.
Setup is fast and easy. Click below to register.
A Flash compatible player was not detected on your system, otherwise you would see videos here. If you can play an mp4, download the video as mp4 here